ECM
DPLO

Empirical Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Empirical Capital Management’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.08M Buy
538,742
+171,810
+47% +$1.77M 2.34% 14
2018
Q4 		$4.94M Sell
366,932
-112,086
-23% -$1.89M 6.66% 8
2018
Q3 		$9.3M Buy
479,018
+27,000
+6% +$575K 8.38% 4
2018
Q2 		$11.6M Buy
+452,018
New +$10.5M 10.87% 3
2015
Q4 		$412K Buy
+12,044
New +$376K 0.45% 27

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Empirical Capital Management's DPLO Position: Q1 2019 in Review

Empirical Capital Management increased its DIPLOMAT PHARMACY, INC. (DPLO) stake by 47% in Q1 2019, buying an estimated $1.77M and bringing the position to 538,742 shares worth $2.08M. The position accounts for 2.34% of the portfolio, ranked #14.

Empirical Capital Management first reported a position in DPLO in Q4 2015 and has held it in 5 quarters since. The position peaked at $11.6M in Q2 2018. 150 funds tracked by Wall St. Rank hold DPLO as of Q1 2019.

  • Empirical Capital Management held 538,742 shares of DIPLOMAT PHARMACY, INC. worth $2.08M as of Q1 2019.
  • Empirical Capital Management bought 171,810 DIPLOMAT PHARMACY, INC. shares in Q1 2019, an estimated $1.77M.
  • DIPLOMAT PHARMACY, INC. made up 2.34% of Empirical Capital Management's portfolio in Q1 2019, its #14 holding.
  • Empirical Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2015 and has held it in 5 quarters since.
  • Empirical Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $11.6M in Q2 2018.
  • 150 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2019.

Based on Empirical Capital Management's 13F filing for Q1 2019, filed 14 May 2019.